| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $62K | +18.0% | +78.3% |
| Cost of Revenue | $9K | +13.0% | +328.6% |
| Gross Profit | $53K | +18.9% | +61.9% |
| R&D Expense | $9K | -71.1% | -94.9% |
| SG&A Expense | $598K | -10.0% | +370.1% |
| Operating Income | -$1.2M | +37.1% | -31.4% |
| Pre-tax Income | -$1.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $28K | -16.6% | +248.6% |
| Inventory | $8K | — | — |
| Current Assets | $6.3M | -18.5% | +1146.9% |
| Total Assets | $20.8M | -3.9% | +102.6% |
| Current Liabilities | $21.2M | +1.0% | +49.7% |
| Long-term Debt | $1.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.6M | — | — |
| Investing Cash Flow | -$3.3M | — | — |
| Financing Cash Flow | $9.7M | — | — |
| -294.2% |
| -16.7% |
| Net Income | -$1.8M | -337.4% | -17.6% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| +0.0% |
| +0.0% |
| Total Liabilities | $36.3M | +0.8% | +127.9% |
| Stockholders' Equity | -$15.8M | -9.9% | -178.9% |